Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.41T | 2.81T | 2.07T | 1.50T | 1.54T | Gross Profit |
911.21B | 1.21T | 868.00B | 543.70B | 555.74B | EBIT |
701.04B | 998.20B | 676.32B | 392.21B | 406.04B | EBITDA |
1.02T | 1.21T | 841.47B | 547.34B | 558.47B | Net Income Common Stockholders |
520.14B | 708.24B | 500.12B | 293.73B | 314.03B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.72T | 1.60T | 1.44T | 1.15T | 1.09T | Total Assets |
5.15T | 4.73T | 4.05T | 3.38T | 3.23T | Total Debt |
24.30B | 29.81B | 30.40B | 27.75B | 23.42B | Net Debt |
-1.67T | -1.42T | -1.08T | -839.13B | -813.03B | Total Liabilities |
723.90B | 704.19B | 624.21B | 493.99B | 507.34B | Stockholders Equity |
4.26T | 3.87T | 3.33T | 2.82T | 2.65T |
Cash Flow | Free Cash Flow | |||
377.70B | 488.65B | 355.97B | 163.80B | 142.96B | Operating Cash Flow |
755.18B | 788.01B | 553.53B | 401.18B | 412.38B | Investing Cash Flow |
-1.10T | -186.49B | -253.72B | -250.72B | -394.55B | Financing Cash Flow |
-369.47B | -423.56B | -122.50B | -91.12B | -94.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $8.94T | 16.80 | 11.81% | 2.39% | 6.06% | 3.97% | |
71 Outperform | €583.70B | 13.52 | 19.18% | 3.90% | 9.83% | 22.31% | |
70 Outperform | $645.17B | 10.01 | 8.00% | 4.68% | 3.51% | 42.02% | |
67 Neutral | $1.00T | 13.35 | 4.16% | 5.04% | <0.01% | -58.95% | |
64 Neutral | $602.92B | 11.93 | 5.83% | 4.49% | 5.15% | -8.48% | |
59 Neutral | €168.15B | 15.36 | 3.51% | 5.32% | 1.62% | 45.83% | |
49 Neutral | $1.96B | -1.23 | -21.20% | 3.72% | 0.95% | -28.96% |